Relief Therapeutics Holding AG (RLFTF)

[GreenKnight]

From the 09/21/2020 PR — 50/50 split in those places for Neuro & RLFTF and an 80/20 split “in favour of RLF” in all other territories.

“They have agreed that NeuroRx will lead commercialization in the United States, Canada, and Israel, while Relief will lead commercialization in Europe and the rest of the world. Profits from sales will be allocated to Relief and NeuroRx on a 50/50 basis in the U.S., Canada and Israel, 85/15 (in favor of Relief) in Europe, and 80/20 (in favor of Relief) in all other territories. ”


https://www.otcmarkets.com/stock/RLFTF/news/Relief-and-NeuroRx-Announce-Partnership-for-Global-Commercialization-of-RLF-100-and-Selection-of-Commercial-Partners?id=274582